Full-Time
Confirmed live in the last 24 hours
Health-tech startup for sustainable weight loss
$120k - $135k/yr
Senior
Remote in USA
Remote-first ways of working, with the flexibility to work from any state.
Calibrate focuses on sustainable weight loss by improving metabolic health instead of relying on traditional dieting methods. Their program combines gradual habit changes with medication that targets underlying biological factors. This approach has reportedly led to a 15% sustained weight loss in real-world settings, distinguishing Calibrate from other weight loss programs. The company operates on a subscription model, often supported by employers as part of employee wellness initiatives, but is also available to individuals. Calibrate uses GLP-1 medications that mimic natural hormones to enhance metabolic function, reduce inflammation, and lower cardiovascular risks. Their goal is to provide an easy-to-maintain program that effectively promotes long-term health and wellness.
Company Size
201-500
Company Stage
Growth Equity (Venture Capital)
Total Funding
$156.6M
Headquarters
New York City, New York
Founded
2020
Help us improve and share your feedback! Did you find this helpful?
Competitive salary with opportunity for equity in an early stage, high growth business
Generous paid time off, including an all-company holiday over Thanksgiving week
Calibrate-funded health benefits (medical, dental, vision) - starting at zero cost to you
One Medical membership and Teladoc virtual care
Fertility, gynecology, and wellness services through Kindbody
Therapy on your time with a free year of Talkspace membership
Health advocacy and assistance services through Health Advocate
Commuter benefits, ClassPass memberships, and gym memberships for post-pandemic life
Remote team with a headquarters in NYC
Competitive Paid Parental Leave for parents
Calibrate secures $100M in series B funding to revolutionize weight treatment.
Rob MacNaughhton, CEO at CalibrateWhat You Should Know:– Calibrate, the leading clinician-guided and value-based obesity treatment program, today announced the appointment of Rob MacNaughton as its new Chief Executive Officer.– Calibrate’s strategic direction under MacNaughton’s leadership and the OptumRx partnership position the company for significant growth and a positive impact on both individual and corporate healthcare landscapes.MacNaughton Bio/BackgroundMacNaughton boasts a distinguished track record in launching new healthcare ventures, overseeing product development, and scaling operations. Prior to Calibrate, MacNaughton served as Venture Chair at Redesign Health, overseeing the launch and growth of several healthcare delivery and technology brands. His previous roles include CEO positions at Curve Health and Nurse Grid, and Chief Product Officer at Cambia Health Solutions, a multi-state Blue Cross Blue Shield payor.“Obesity is the largest category of chronic disease and one of the biggest drivers of healthcare spending. I’m honored to join a company at the forefront of value-based obesity care and a business that is clearly committed to addressing the epidemic head on while helping employers and insurers manage soaring costs,” said Calibrate CEO, Rob MacNaughton. “Our commercial momentum is stronger than ever, and we are confident we will continue to collaborate with industry leaders to deliver best-in-class sustained outcomes.”
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Calibrate, the weight loss startup that rose in popularity with the rise of GLP-1 medications only to struggle to get patients access to those medications — leading to patient complaints and refunds
Weight loss startup Calibrate raises $29M as part of private equity restructuring.
Weight-loss startup Calibrate is selling itself to the private equity firm Madryn Asset Management, Insider has learned.